Ganciclovir Completed Phase 3 Trials for Infection NOS Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care3
clinicaltrials.gov IdentifierTitleDrugs
NCT00016068Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation